Inventprise Announces Investment Of Up To $90 Million To Advance Its 25 Valent Pneumococcal Conjugate Vaccine Candidate Into Proof-Of-Concept Clinical Trials
Round Type
Venture
RedmondBiotechnologyDescription
Inventprise, a biotechnology company specializing in novel, affordable and highly impactful vaccines, announced today that the Bill & Melinda Gates Foundation, a global non-profit organization, has made a program-related investment in the company’s continued development of IVT-25, an investigational pneumococcal conjugate vaccine designed to prevent pneumococcal bacterial infections. Pneumonia remains the single largest infectious cause of death in children worldwide. The investment, made by the foundation’s Strategic Investment Fund, will support development activities through completion of Phase 1 and Phase 2 clinical studies to assess safety and immunological proof-of-concept. The foundation will fund up to $90 million with the successful achievement of future manufacturing, preclinical and clinical development milestones.
Quick answer
Inventprise raised an undisclosed amount in a funding round, dated November 10, 2021. Inventprise is based in Redmond, Washington, United States.
- How much did Inventprise raise?
- Inventprise raised an undisclosed amount in a funding round on November 10, 2021.
- What does Inventprise do?
- Inventprise is a biopharmaceutical company leveraging its innovative platform technology to develop vaccines against infectious diseases, with an initial focus on invasive pneumococcal disease.
- Where is Inventprise based and how big is it?
- Inventprise is based in Redmond, Washington, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Inventprise that raised within 45 days of this round, from Fundz verified event records.
- Rhaeos raised $2.2M (Seed) on December 24, 2021.
- EIP Pharma, Inc. raised $6M on December 23, 2021.
- Arcutis raised $225M (Debt Financing) on December 23, 2021.
- Appili Therapeutics Inc. raised an undisclosed amount (Funding Round) on December 22, 2021.
- TandemAI raised $25M (Seed) on December 22, 2021.
- MyndTec raised $79K on December 22, 2021.
Who to call at Inventprise, and when
A new round usually means Inventprise is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Inventprise raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inventprise, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inventprise. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inventprise raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Inventprise raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.